Kaur A, Kaushik P, Narayana S, Rajanna A, Bhat A, Appaji L
Autops Case Rep. 2024; 14:e2024504.
PMID: 39176106
PMC: 11340816.
DOI: 10.4322/acr.2024.504.
Jeyaraj R, Kelly D
Cells. 2022; 11(16).
PMID: 36010647
PMC: 9406938.
DOI: 10.3390/cells11162570.
Vitale G, Mattiaccio A, Conti A, Turco L, Seri M, Piscaglia F
Cancers (Basel). 2022; 14(14).
PMID: 35884482
PMC: 9322180.
DOI: 10.3390/cancers14143421.
Fu J, Yu M, Xu W, Yu S
Front Oncol. 2022; 11:778258.
PMID: 35127481
PMC: 8810494.
DOI: 10.3389/fonc.2021.778258.
Gul-Klein S, Ollinger R, Schmelzle M, Pratschke J, Schoning W
Medicina (Kaunas). 2021; 57(8).
PMID: 34441060
PMC: 8400732.
DOI: 10.3390/medicina57080854.
Glibenclamide, ATP and metformin increases the expression of human bile salt export pump ABCB11.
Vats N, Dubey R, Sanal M, Taneja P, Venugopal S
F1000Res. 2021; 9:1497.
PMID: 33763207
PMC: 7953918.
DOI: 10.12688/f1000research.26632.1.
Gene Therapy for Progressive Familial Intrahepatic Cholestasis: Current Progress and Future Prospects.
Bosma P, Wits M, Oude-Elferink R
Int J Mol Sci. 2021; 22(1).
PMID: 33383947
PMC: 7796371.
DOI: 10.3390/ijms22010273.
Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma.
Marin J, Macias R, Cives-Losada C, Peleteiro-Vigil A, Herraez E, Lozano E
Cells. 2020; 9(2).
PMID: 32098199
PMC: 7072733.
DOI: 10.3390/cells9020498.
Comprehensive analysis of DNA methylation and gene expression profiles in cholangiocarcinoma.
Zhang C, Zhang B, Meng D, Ge C
Cancer Cell Int. 2020; 19:352.
PMID: 31889904
PMC: 6933876.
DOI: 10.1186/s12935-019-1080-y.
Inherited disorders of cholestasis in adulthood.
Bass L, Kamath B
Clin Liver Dis (Hoboken). 2019; 2(5):200-203.
PMID: 30992862
PMC: 6448654.
DOI: 10.1002/cld.245.
Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in mice.
Wang R, Sheps J, Liu L, Han J, Chen P, Lamontagne J
J Lipid Res. 2018; 60(1):85-97.
PMID: 30416103
PMC: 6314265.
DOI: 10.1194/jlr.M088070.
Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases.
Chen H, Wu S, Hsu S, Liou B, Chen H, Chang M
J Biomed Sci. 2018; 25(1):75.
PMID: 30367658
PMC: 6203212.
DOI: 10.1186/s12929-018-0475-8.
New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications.
Sticova E, Jirsa M, Pawlowska J
Can J Gastroenterol Hepatol. 2018; 2018:2313675.
PMID: 30148122
PMC: 6083523.
DOI: 10.1155/2018/2313675.
Clinical phenotype and molecular analysis of a homozygous ABCB11 mutation responsible for progressive infantile cholestasis.
Imagawa K, Hayashi H, Sabu Y, Tanikawa K, Fujishiro J, Kajikawa D
J Hum Genet. 2018; 63(5):569-577.
PMID: 29507376
DOI: 10.1038/s10038-018-0431-1.
Generation of a bile salt export pump deficiency model using patient-specific induced pluripotent stem cell-derived hepatocyte-like cells.
Imagawa K, Takayama K, Isoyama S, Tanikawa K, Shinkai M, Harada K
Sci Rep. 2017; 7:41806.
PMID: 28150711
PMC: 5288783.
DOI: 10.1038/srep41806.
Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis.
Wang K, Tiao G, Bass L, Hertel P, Mogul D, Kerkar N
Hepatology. 2016; 65(5):1645-1654.
PMID: 28027587
PMC: 5397365.
DOI: 10.1002/hep.29019.
Liver transplantation and the management of progressive familial intrahepatic cholestasis in children.
Mehl A, Bohorquez H, Serrano M, Galliano G, Reichman T
World J Transplant. 2016; 6(2):278-90.
PMID: 27358773
PMC: 4919732.
DOI: 10.5500/wjt.v6.i2.278.
Clinical and ABCB11 profiles in Korean infants with progressive familial intrahepatic cholestasis.
Park J, Ko J, Seo J, Moon J, Park S
World J Gastroenterol. 2016; 22(20):4901-7.
PMID: 27239116
PMC: 4873882.
DOI: 10.3748/wjg.v22.i20.4901.
Liver tumors in children with metabolic disorders.
Schady D, Roy A, Finegold M
Transl Pediatr. 2016; 4(4):290-303.
PMID: 26835391
PMC: 4728996.
DOI: 10.3978/j.issn.2224-4336.2015.10.08.
Progressive familial intrahepatic cholestasis.
Srivastava A
J Clin Exp Hepatol. 2015; 4(1):25-36.
PMID: 25755532
PMC: 4017198.
DOI: 10.1016/j.jceh.2013.10.005.